Champignon Brands' CRTCE Clinic is the First Multidisciplinary Community Clinic in Canada to Offer Rapid-Onset Treatments for Depression and Expects to Be the First of its Kind to Provide the... read more →
Psychedelics Companies That Own Clinics May Hold the Answer to One of the Top Investor Questions: "How Will Individual Firms Generate Meaningful Revenue?" As We Know, the Business of Biotech... read more →
Early Weed Investors and Business Minds are Positioning Themselves in the World of Psychedelic Medicine as the Flow of Smart Money Hits the Market Canopy Growth Founder Bruce Linton and... read more →
The First Drug in the Psychedelics Space, Ketamine-Based Spravato By J&J Was Approved Last Year At $6,700 a Month, Spravato is Expected to Generate Well North of $1.3 Billion Annually... read more →
Champignon Advances Psychedelic Clinic Expansion Announcing Terms for First U.S. Acquisition of California-Based Wellness Clinic of Orange County Today's News Comes Just One Day After the Psychedelics Company Announced Dr.... read more →
AltMed Owns a Fully Operational Ketamine Clinic Located Near Toronto, Ontario AltMed's Psychedelics Clinic is Licensed by Health Canada to Dose Eligible Patients with Psilocybin and is the Only Clinic... read more →
